Swedish Orphan Biovitrum AB (publ)

OTCPK:SWOB.Y Stock Report

Market Cap: US$11.1b

Swedish Orphan Biovitrum Management

Management criteria checks 4/4

Swedish Orphan Biovitrum's CEO is Guido Oelkers, appointed in May 2017, has a tenure of 7.33 years. total yearly compensation is SEK48.88M, comprised of 25.1% salary and 74.9% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $13.79M. The average tenure of the management team and the board of directors is 5.7 years and 3.8 years respectively.

Key information

Guido Oelkers

Chief executive officer

SEK 48.9m

Total compensation

CEO salary percentage25.1%
CEO tenure7.3yrs
CEO ownership0.1%
Management average tenure5.7yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Guido Oelkers's remuneration changed compared to Swedish Orphan Biovitrum's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

SEK 2b

Mar 31 2024n/an/a

SEK 2b

Dec 31 2023SEK 49mSEK 12m

SEK 2b

Sep 30 2023n/an/a

SEK 3b

Jun 30 2023n/an/a

SEK 3b

Mar 31 2023n/an/a

SEK 3b

Dec 31 2022SEK 47mSEK 11m

SEK 3b

Sep 30 2022n/an/a

SEK 2b

Jun 30 2022n/an/a

SEK 3b

Mar 31 2022n/an/a

SEK 3b

Dec 31 2021SEK 42mSEK 10m

SEK 3b

Sep 30 2021n/an/a

SEK 3b

Jun 30 2021n/an/a

SEK 3b

Mar 31 2021n/an/a

SEK 3b

Dec 31 2020SEK 33mSEK 10m

SEK 3b

Sep 30 2020n/an/a

SEK 3b

Jun 30 2020n/an/a

SEK 3b

Mar 31 2020n/an/a

SEK 4b

Dec 31 2019SEK 33mSEK 10m

SEK 3b

Sep 30 2019n/an/a

SEK 3b

Jun 30 2019n/an/a

SEK 3b

Mar 31 2019n/an/a

SEK 3b

Dec 31 2018SEK 26mSEK 9m

SEK 2b

Sep 30 2018n/an/a

SEK 2b

Jun 30 2018n/an/a

SEK 2b

Mar 31 2018n/an/a

SEK 1b

Dec 31 2017SEK 16mSEK 5m

SEK 1b

Compensation vs Market: Guido's total compensation ($USD4.84M) is below average for companies of similar size in the US market ($USD13.03M).

Compensation vs Earnings: Guido's compensation has been consistent with company performance over the past year.

CEO

Guido Oelkers (59 yo)

7.3yrs

Tenure

SEK 48,883,000

Compensation

Dr. Guido Oelkers is a Director of Dova Pharmaceuticals Inc. since November 12, 2019. Dr. Oelkers has been the Chief Executive Officer and President at Swedish Orphan Biovitrum AB since May 22, 2017. He se...

Leadership Team

NamePositionTenureCompensationOwnership
Guido Oelkers
CEO & President7.3yrsSEK 48.88m0.12%
SEK 13.8m
Henrik Stenqvist
Chief Financial Officer6.2yrsno data0.016%
SEK 1.8m
Torbjörn Hallberg
General Counsel & Head of Legal Affairs5.7yrsno data0.0089%
SEK 984.5k
Daniel Rankin
Head of Strategy & Corporate Development2.7yrsno data0.0029%
SEK 316.7k
Lena Bjurner
Head of Human Resources1.7yrsno datano data
Armin Reininger
Senior Scientific & Medical Advisor7.7yrsno data0.0046%
SEK 516.7k
Norbert Oppitz
Head of International6.9yrsno data0.012%
SEK 1.3m
Sofiane Fahmy
Head of Europe5.7yrsno data0.0077%
SEK 856.7k
Duane Barnes
Head of North America3.7yrsno datano data
Mahmood Ladha
Head of Strategic Transformation Operationsno datano data0.0018%
SEK 202.2k
Christine Wesstrom
Head of Technical Operations2.5yrsno data0.0032%
SEK 356.7k
Lydia Abad-Franch
Senior VP1.7yrsno datano data

5.7yrs

Average Tenure

56.5yo

Average Age

Experienced Management: SWOB.Y's management team is seasoned and experienced (5.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hans Wigzell
Chairman of Scientific Advisory Board23.7yrsSEK 158.00kno data
Helena Saxon
Director13.4yrsSEK 828.00k0.0066%
SEK 737.8k
Anders Ullman
Director1.3yrsSEK 463.00k0.0010%
SEK 111.1k
Stephen O'Rahilly
Member of Scientific Advisory Boardno datano datano data
Ralf Pettersson
Member of Scientific Advisory Boardno datano datano data
Stefan Del Prato
Member of Scientific Advisory Boardno datano datano data
Jonathan Sanders Arch
Member of Scientific Advisory Boardno datano datano data
Annette Clancy
Independent Chairman10.3yrsSEK 770.00k0.00099%
SEK 110.0k
Staffan Schuberg
Independent Director4.3yrsSEK 827.00k0.0021%
SEK 231.1k
Filippa Stenberg
Director3.3yrsSEK 673.00k0.00017%
SEK 18.9k
Katy Mazibuko
Employee Representative Director1.7yrsno data0.0013%
SEK 141.1k
Christophe Bourdon
Independent Director1.3yrsSEK 433.00kno data

3.8yrs

Average Tenure

54.5yo

Average Age

Experienced Board: SWOB.Y's board of directors are considered experienced (3.8 years average tenure).